Follow
Viswanadh MK
Viswanadh MK
Associate Professor, KL College of Pharmacy, KL Deemed to be University, Vijayawada, AP
Verified email at itbhu.ac.in
Title
Cited by
Cited by
Year
Nanotheranostics: emerging strategies for early diagnosis and therapy of brain cancer
MK Viswanadh, RP Singh, P Agrawal, AK Mehata, DM Pawde, R Sonkar, ...
Nanotheranostics 2 (1), 70, 2018
1302018
Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy
AK Mehata, S Bharti, P Singh, MK Viswanadh, L Kumari, P Agrawal, ...
Colloids and Surfaces B: Biointerfaces 173, 366-377, 2019
932019
EGFR targeted paclitaxel and piperine co-loaded liposomes for the treatment of triple negative breast cancer
AS Burande, MK Viswanadh, A Jha, AK Mehata, A Shaik, N Agrawal, ...
AAPS PharmSciTech 21, 1-12, 2020
542020
Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment
MK Viswanadh, AK Mehata, V Sharma, V Priya, N Varshney, SK Mahto, ...
Carbohydrate Polymers 274, 118617, 2021
422021
Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis
DM Pawde, MK Viswanadh, AK Mehata, R Sonkar, S Poddar, AS Burande, ...
Saudi Pharmaceutical Journal 28 (12), 1616-1625, 2020
412020
DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer
A Jha, MK Viswanadh, AS Burande, AK Mehata, S Poddar, K Yadav, ...
International journal of biological macromolecules 150, 413-425, 2020
322020
Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics
R Sonkar, A Jha, MK Viswanadh, AS Burande, DM Pawde, KK Patel, ...
Materials Science and Engineering: C 120, 111652, 2021
282021
Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy
MK Viswanadh, N Agrawal, S Azad, A Jha, S Poddar, SK Mahto, ...
International Journal of Pharmaceutics 602, 120652, 2021
272021
Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy
MK Viswanadh, Vikas, A Jha, SK Reddy Adena, AK Mehata, V Priya, ...
Nanomedicine 15 (24), 2345-2367, 2020
272020
WNT-β catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective
K Ramakrishna, LV Nalla, D Naresh, K Venkateswarlu, MK Viswanadh, ...
Diseases 11 (3), 89, 2023
252023
Theranostic magnetic nanoparticles: Synthesis, properties, toxicity, and emerging trends for biomedical applications
A Setia, AK Mehata, AK Malik, MK Viswanadh, MS Muthu
Journal of Drug Delivery Science and Technology 81, 104295, 2023
182023
Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy
MS Muthu, AK Mehata, MK Viswanadh
Nanomedicine 12 (6), 577-580, 2017
182017
Fast and highly efficient liquid chromatographic methods for qualification and quantification of antibiotic residues from environmental waste
AK Mehata, MNL Suseela, P Gokul, AK Malik, MK Viswanadh, C Singh, ...
Microchemical Journal 179, 107573, 2022
172022
Advances in solid-phase extraction techniques: Role of nanosorbents for the enrichment of antibiotics for analytical quantification
MNL Suseela, MK Viswanadh, AK Mehata, V Priya, A Setia, AK Malik, ...
Journal of Chromatography A 1695, 463937, 2023
162023
Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer
Narendra, AK Mehata, MK Viswanadh, R Sonkar, DM Pawde, V Priya, ...
Therapeutic Delivery 11 (9), 557-571, 2020
162020
Dendritic cell-targeted theranostic nanomedicine: advanced cancer nanotechnology for diagnosis and therapy
AK Mehata, MK Viswanadh, V Priya, Vikas, MS Muthu
Nanomedicine 15 (10), 947-949, 2020
162020
Targeted bioadhesive nanomedicine: an effective approach for synergistic drug delivery to cancers
MK Viswanadh, MS Muthu
Nanomedicine 13 (12), 1401-1403, 2018
162018
Physical and in-vitro evaluation of ϵ-Fe3N@ Fe3O4 nanoparticles for bioapplications
A Gangwar, SS Varghese, SS Meena, CL Prajapat, MK Viswanadh, ...
Ceramics International 46 (8), 10952-10962, 2020
142020
Structural and in-vitro assessment of ZnxFe3− xC (0≤ x≤ 1) nanoparticles as magnetic biomaterials
A Gangwar, S Kumar, SS Meena, A Sharma, MK Viswanadh, K Neogi, ...
Applied Surface Science 509, 144891, 2020
122020
Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis
V Priya, MK Viswanadh, AK Mehata, D Jain, SK Singh, MS Muthu
Nanomedicine 16 (13), 1153-1176, 2021
92021
The system can't perform the operation now. Try again later.
Articles 1–20